Colinz Laboratories Stock Screener | Share Price & Fundamental Analysis
COLINZ
Pharmaceuticals
Share Price BSE
₹45.26
▼
-2.03 (-4.29%)
Track Colinz Laboratories share price live with TickJournal's free stock screener.
Analyze Colinz Laboratories share price history trends and compare 52-week high low
levels.
Calculate COLINZ stock fair value using fundamental analysis and view live share price charts.
Determine Colinz Laboratories share intrinsic value and compare it with current COLINZ share price.
Record your Colinz Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Colinz Laboratories Market Cap
₹24.20 Cr.
COLINZ P/E Ratio (TTM)
15.00
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.07
COLINZ 52 Week High
₹84.48
Colinz Laboratories 52 Week Low
₹38.64
Operating Margin
7.00%
Profit Margin
16.67%
COLINZ Revenue (TTM)
₹6.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹12.00
Total Equity
₹10.00
Colinz Laboratories Share Price History - Stock Screener Chart
Screen COLINZ historical share price movements with interactive charts. Analyze price trends and patterns.
Colinz Laboratories Company Profile - Fundamental Screener
Screen Colinz Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for COLINZ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE923C01011
Colinz Laboratories Balance Sheet Screener
Screen COLINZ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Current Assets | 9 | 9 | 8 | 7 | 7 | 6 | 6 | 6 | 5 | 5 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 6 |
| Share Capital | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 7 | 6 | 6 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
Colinz Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Colinz Laboratories income statement and profit fundamentals.
Analyze COLINZ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Colinz Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 7 | 7 | 7 | 6 | 8 | 8 | 8 | 8 | 8 | 8 |
| Expenses | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 7.00% | 8.00% | 8.00% | 9.00% | 8.00% | 5.00% | 4.00% | 5.00% | 5.00% | 5.00% | 6.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 1.80 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | -0.01 | 0.34 | 0.65 | 0.40 | 0.21 | 0.21 |
Colinz Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen COLINZ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Cash Flow | -2 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Colinz Laboratories Shareholding Pattern Screener
See Colinz Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Colinz Laboratories promoter holding and ownership changes for COLINZ on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.44% | 31.04% | 30.97% | 31.09% | 30.95% | 31.04% | 31.01% | 31.88% |
| Other Holding | 3.56% | 2.95% | 3.03% | 2.91% | 3.05% | 2.96% | 2.99% | 2.00% |
| Shareholder Count | 3,216 | 3,238 | 3,272 | 2,929 | 2,980 | 3,116 | 3,202 | 2,863 |
Colinz Laboratories Share Dividend Screener - Share Yield Analysis
Check Colinz Laboratories dividend history with payout and yield data.
View Colinz Laboratories dividend details including ex-dates and amounts for COLINZ stock.
Colinz Laboratories Stock Index Membership
See which indices include Colinz Laboratories stock.
Check COLINZ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Colinz Laboratories Market Events Screener - Corporate Actions
Get Colinz Laboratories corporate actions including splits, bonuses, and buybacks.
Check Colinz Laboratories stock events that may affect COLINZ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.86% | ||
| Annual General Meeting | NA | -8.26% | ||
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.94% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 12.74% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 13.57% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -3.37% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 4.60% |
Colinz Laboratories Competitors Screener - Peer Comparison
Screen COLINZ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,177 | 40.80 | 54,729 | 9.71% | 10,980 | 55.31 |
| Divis Laboratories | 167,059 | 67.69 | 9,712 | 18.67% | 2,191 | 40.39 |
| Torrent Pharmaceuticals | 127,621 | 59.43 | 11,539 | 6.99% | 1,911 | 55.07 |
| Cipla | 120,913 | 22.30 | 28,410 | 7.12% | 5,291 | 42.59 |
| Dr Reddys Laboratories | 106,163 | 18.61 | 33,741 | 16.73% | 5,725 | 55.82 |
| Lupin | 96,517 | 21.96 | 22,910 | 13.74% | 3,306 | 62.97 |
| Zydus Life Science | 92,382 | 18.29 | 23,511 | 18.55% | 4,615 | 38.19 |
| Mankind Pharma | 87,142 | 49.02 | 12,744 | 20.90% | 2,007 | 26.69 |
| Aurobindo Pharma | 69,290 | 20.00 | 32,346 | 9.43% | 3,484 | 51.87 |
| Alkem Laboratories | 67,297 | 28.08 | 13,458 | 3.70% | 2,216 | 48.73 |
Colinz Laboratories Company Announcements - News Screener
Screen COLINZ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-27 | Submissions Of Disclosers Under Regulation 7(2) Of SEBI PIT Regulation 2015 | View |
| 2026-02-27 | Disclosure Under Regulation 29(2) Of SEBI SAST Regulations 2011 | View |
| 2026-02-27 | Regulation 10(6) Of SEBI (SAST) Regulation 29(2) | View |
| 2025-11-27 | REVISED Outcome Of The Board Meeting | View |
| 2025-11-27 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-11-27 | Outcome Of The Board Meeting | View |
| 2025-11-27 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-11-27 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-24 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-11 | Intimation Regarding Appointment Of Additional Director (Non-Executive Non-Independent Director.) | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-08 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Demise | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-03 | FIANACIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30-9-2025 | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |